Helix BioPharma Corp (HBPCF)
0.1377
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Helix BioPharma Price to Book Value: 70.25 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 70.25 |
| May 02, 2024 | 70.25 |
| May 01, 2024 | 70.25 |
| April 30, 2024 | 70.25 |
| April 29, 2024 | 70.25 |
| April 26, 2024 | 70.25 |
| April 25, 2024 | 70.25 |
| April 24, 2024 | 70.25 |
| April 23, 2024 | 70.25 |
| April 22, 2024 | 70.25 |
| April 19, 2024 | 70.25 |
| April 18, 2024 | 70.25 |
| April 17, 2024 | 70.25 |
| April 16, 2024 | 70.25 |
| April 15, 2024 | 70.25 |
| April 12, 2024 | 70.25 |
| April 11, 2024 | 70.25 |
| April 10, 2024 | 70.25 |
| April 09, 2024 | 70.25 |
| April 08, 2024 | 70.25 |
| April 05, 2024 | 66.34 |
| April 04, 2024 | 66.34 |
| April 03, 2024 | 66.34 |
| April 02, 2024 | 66.34 |
| April 01, 2024 | 66.34 |
| Date | Value |
|---|---|
| March 28, 2024 | 66.34 |
| March 27, 2024 | 66.34 |
| March 26, 2024 | 66.34 |
| March 25, 2024 | 71.30 |
| March 22, 2024 | 71.30 |
| March 21, 2024 | 71.30 |
| March 20, 2024 | 71.30 |
| March 19, 2024 | 71.30 |
| March 18, 2024 | 68.07 |
| March 15, 2024 | 68.07 |
| March 14, 2024 | 68.07 |
| March 13, 2024 | 68.07 |
| March 12, 2024 | 68.07 |
| March 11, 2024 | 68.07 |
| March 08, 2024 | 68.07 |
| March 07, 2024 | 68.07 |
| March 06, 2024 | 68.07 |
| March 05, 2024 | 68.07 |
| March 04, 2024 | 68.07 |
| March 01, 2024 | 68.07 |
| February 29, 2024 | 68.07 |
| February 28, 2024 | 69.85 |
| February 27, 2024 | 69.85 |
| February 26, 2024 | 69.85 |
| February 23, 2024 | 69.85 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
15.26
Minimum
Dec 28 2020
3961.04
Maximum
Jan 22 2020
357.99
Average
43.39
Median
May 15 2023
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.4302 |
| Aurinia Pharmaceuticals Inc | 1.930 |
| Edesa Biotech Inc | 2.514 |
| Lexaria Bioscience Corp | 6.185 |
| Xenon Pharmaceuticals Inc | 3.558 |
Price to Book Value Related Metrics
| Price | 0.1377 |
| Earnings Yield | -19.75% |
| Market Cap | 31.59M |